Plimoth Trust CO LLC Gilead Sciences, Inc. Transaction History

Plimoth Trust CO LLC

$371 Million
Q1 2024

A detailed history of Plimoth Trust CO LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Plimoth Trust CO LLC holds 7,785 shares of GILD stock, worth $532,494. This represents 0.15% of its overall portfolio holdings.

Number of Shares

7,785

Previous 9,240 15.75%

Holding current value

$532,494

Previous $748,000 23.8%

% of portfolio

0.15%

Previous 0.22%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	SELL	$71.58 - $87.29 $104,148 - $127,006	-1,455 Reduced 15.75%	7,785 $570,000
Q4 2023 Jan 26, 2024	SELL	$73.27 - $83.09 $732 - $830	-10 Reduced 0.11%	9,240 $748,000
Q2 2023 Jul 21, 2023	SELL	$76.01 - $86.7 $3,800 - $4,335	-50 Reduced 0.54%	9,250 $712,000
Q1 2023 Apr 26, 2023	SELL	$77.31 - $88.08 $13,529 - $15,414	-175 Reduced 1.85%	9,300 $771,000
Q4 2022 Jan 19, 2023	SELL	$62.32 - $89.47 $14,645 - $21,025	-235 Reduced 2.42%	9,475 $814,000

Q3 2022 Oct 18, 2022	SELL	$59.54 - $68.01 $5,954 - $6,801	-100 Reduced 1.02%	9,710 $600,000
Q2 2022 Jul 15, 2022	BUY	$57.72 - $65.01 $3,751 - $4,225	65 Added 0.67%	9,810 $607,000
Q1 2022 Apr 25, 2022	SELL	$57.92 - $72.58 $20,851 - $26,128	-360 Reduced 3.56%	9,745 $580,000
Q4 2021 Jan 27, 2022	SELL	$64.88 - $73.64 $25,952 - $29,456	-400 Reduced 3.81%	10,105 $734,000
Q3 2021 Oct 22, 2021	SELL	$67.69 - $73.03 $50,564 - $54,553	-747 Reduced 6.64%	10,505 $734,000
Q2 2021 Jul 20, 2021	SELL	$63.47 - $69.35 $225,635 - $246,539	-3,555 Reduced 24.01%	11,252 $775,000
Q1 2021 Apr 14, 2021	SELL	$60.0 - $68.46 $123,240 - $140,616	-2,054 Reduced 12.18%	14,807 $957,000
Q4 2020 Jan 22, 2021	SELL	$56.65 - $64.55 $297,979 - $339,533	-5,260 Reduced 23.78%	16,861 $982,000
Q3 2020 Oct 27, 2020	SELL	$62.1 - $78.08 $414,641 - $521,340	-6,677 Reduced 23.19%	22,121 $1.4 Million
Q2 2020 Jul 20, 2020	SELL	$72.34 - $84.0 $159,075 - $184,716	-2,199 Reduced 7.09%	28,798 $2.22 Million
Q1 2020 Apr 22, 2020	SELL	$62.63 - $80.22 $59,936 - $76,770	-957 Reduced 2.99%	30,997 $2.32 Million
Q4 2019 Jan 29, 2020	SELL	$61.62 - $67.78 $65,193 - $71,711	-1,058 Reduced 3.2%	31,954 $2.08 Million
Q3 2019 Oct 28, 2019	SELL	$62.51 - $69.0 $584,405 - $645,081	-9,349 Reduced 22.07%	33,012 $2.09 Million
Q2 2019 Aug 05, 2019	SELL	$61.87 - $69.38 $149,416 - $167,552	-2,415 Reduced 5.39%	42,361 $2.86 Million
Q1 2019 Apr 19, 2019	BUY	$62.53 - $70.05 $15,319 - $17,162	245 Added 0.55%	44,776 $2.91 Million
Q4 2018 Jan 25, 2019	BUY	$60.54 - $79.0 $40,864 - $53,325	675 Added 1.54%	44,531 $2.79 Million
Q3 2018 Dec 13, 2018	BUY	$71.28 - $78.92 $26,017 - $28,805	365 Added 0.84%	43,856 $3.39 Million
Q2 2018 Dec 12, 2018	BUY	$64.88 - $75.68 $159,280 - $185,794	2,455 Added 5.98%	43,491 $3.08 Million
Q1 2018 Dec 21, 2018	BUY	$72.84 - $88.8 $212,255 - $258,763	2,914 Added 7.64%	41,036 $3.09 Million
Q4 2017 Dec 26, 2018	BUY	$71.15 - $83.52 $2.71 Million - $3.18 Million	38,122	38,122 $2.73 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $85.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Plimoth Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plimoth Trust CO LLC with notifications on news.

Account

Plimoth Trust CO LLC Gilead Sciences, Inc. Transaction History